JP2005508169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508169A5 JP2005508169A5 JP2003539603A JP2003539603A JP2005508169A5 JP 2005508169 A5 JP2005508169 A5 JP 2005508169A5 JP 2003539603 A JP2003539603 A JP 2003539603A JP 2003539603 A JP2003539603 A JP 2003539603A JP 2005508169 A5 JP2005508169 A5 JP 2005508169A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- seq
- nucleic acid
- amino acid
- nucleotide sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33500601P | 2001-10-31 | 2001-10-31 | |
| PCT/US2002/034574 WO2003037257A2 (en) | 2001-10-31 | 2002-10-29 | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508169A JP2005508169A (ja) | 2005-03-31 |
| JP2005508169A5 true JP2005508169A5 (cg-RX-API-DMAC7.html) | 2006-01-05 |
Family
ID=23309830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003539603A Pending JP2005508169A (ja) | 2001-10-31 | 2002-10-29 | ２０７５０を使用した細胞増殖障害の診断および処置のための方法および組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20030108937A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1440080A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005508169A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002363228A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003037257A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003037257A2 (en) * | 2001-10-31 | 2003-05-08 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| US8003315B2 (en) * | 2001-12-13 | 2011-08-23 | Exelixis, Inc. | TAOJIKs as modifiers of the beta-catenin pathway and methods of use |
| US20030224406A1 (en) * | 2002-03-01 | 2003-12-04 | Costa Michael A. | MBCATs as modifiers of the beta-catenin pathway and methods of use |
| EP1687405A4 (en) * | 2003-11-24 | 2007-10-31 | Exelixis Inc | Ttbks as modifiers of the beta catenin pathway and methods of use |
| US20070128666A1 (en) * | 2003-11-24 | 2007-06-07 | Helen Francis-Lang | Ttbks as modifiers of the beta catenin pathway and methods of use |
| US20090099062A1 (en) * | 2007-05-31 | 2009-04-16 | Ethan Lee | Pyrvinium For The Treatment of Cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000073469A2 (en) * | 1999-05-28 | 2000-12-07 | Sugen, Inc. | Protein kinases |
| US20020151020A1 (en) * | 2001-04-16 | 2002-10-17 | Xianghe Yan | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| WO2003037257A2 (en) * | 2001-10-31 | 2003-05-08 | Millennium Pharmaceuticals, Inc. | Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
-
2002
- 2002-10-29 WO PCT/US2002/034574 patent/WO2003037257A2/en not_active Ceased
- 2002-10-29 EP EP02802476A patent/EP1440080A4/en not_active Withdrawn
- 2002-10-29 JP JP2003539603A patent/JP2005508169A/ja active Pending
- 2002-10-29 AU AU2002363228A patent/AU2002363228A1/en not_active Abandoned
- 2002-10-30 US US10/284,060 patent/US20030108937A1/en not_active Abandoned